JPRN-UMIN000007111已完成未知
The effects of vildagliptin as a DPPIV inhibitor on vascular endothelial and myocardial injury in patients with type II diabetes mellitus. - The effects of vildagliptin as a DPPIV inhibitor on vascular endothelial and myocardial injury in patients with type II diabetes mellitus.
ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine0 个研究点目标入组 40 人开始时间: 2012年1月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type I diabetes mellitus 2) Patients receiving insulin therapy 3) Severe renal dysfunction requiring hemodialysis or peritoneal dialysis 4) Severe hepatopathy/nephropathy or heart disease that may affect the evaluation of drug safety 5) Patients who are deemed to be inappropriate by the investigator or sub-investigators
研究者
相似试验
已完成
不适用
The effects of sitagliptin as a DPPIV inhibitor on vascular endothelial and autonomic nerve functions in patients with type II diabetes mellitus.Type II diabetes mellitusJPRN-UMIN000004236ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine40
进行中（未招募）
1 期
correlation between gastric motility and appetitehealthy volunteersno medical condition, drug will be studied because they are known to influence gastric motilityEUCTR2013-004978-95-BEKULeuven14
Unknown
3 期
Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes MellitusInsulin Dependent DiabetesJuvenile Onset Diabetes MellitusAutoimmune DiabetesType 1 DiabetesNCT01559025Federal University of São Paulo44
终止
2 期
Sitagliptin in Cystic Fibrosis-Related DiabetesCystic FibrosisNCT01257464University of British Columbia3
进行中（未招募）
1 期
Study of the Effect of Vildagliptin versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects with Type 2 DiabetesType 2 Diabetes MellitusEUCTR2015-001334-21-SEund University